Predicting Depressive Symptom Severity Through Individuals' Nearby Bluetooth Device Count Data Collected by Mobile Phones: Preliminary Longitudinal Study.

Bluetooth depression digital biomarkers digital health digital phenotyping hierarchical Bayesian model mHealth mental health mobile health monitoring

Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
30 07 2021
Historique:
received: 23 04 2021
accepted: 31 05 2021
revised: 18 05 2021
entrez: 30 7 2021
pubmed: 31 7 2021
medline: 11 8 2021
Statut: epublish

Résumé

Research in mental health has found associations between depression and individuals' behaviors and statuses, such as social connections and interactions, working status, mobility, and social isolation and loneliness. These behaviors and statuses can be approximated by the nearby Bluetooth device count (NBDC) detected by Bluetooth sensors in mobile phones. This study aimed to explore the value of the NBDC data in predicting depressive symptom severity as measured via the 8-item Patient Health Questionnaire (PHQ-8). The data used in this paper included 2886 biweekly PHQ-8 records collected from 316 participants recruited from three study sites in the Netherlands, Spain, and the United Kingdom as part of the EU Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) study. From the NBDC data 2 weeks prior to each PHQ-8 score, we extracted 49 Bluetooth features, including statistical features and nonlinear features for measuring the periodicity and regularity of individuals' life rhythms. Linear mixed-effect models were used to explore associations between Bluetooth features and the PHQ-8 score. We then applied hierarchical Bayesian linear regression models to predict the PHQ-8 score from the extracted Bluetooth features. A number of significant associations were found between Bluetooth features and depressive symptom severity. Generally speaking, along with depressive symptom worsening, one or more of the following changes were found in the preceding 2 weeks of the NBDC data: (1) the amount decreased, (2) the variance decreased, (3) the periodicity (especially the circadian rhythm) decreased, and (4) the NBDC sequence became more irregular. Compared with commonly used machine learning models, the proposed hierarchical Bayesian linear regression model achieved the best prediction metrics (R Our statistical results indicate that the NBDC data have the potential to reflect changes in individuals' behaviors and statuses concurrent with the changes in the depressive state. The prediction results demonstrate that the NBDC data have a significant value in predicting depressive symptom severity. These findings may have utility for the mental health monitoring practice in real-world settings.

Sections du résumé

BACKGROUND
Research in mental health has found associations between depression and individuals' behaviors and statuses, such as social connections and interactions, working status, mobility, and social isolation and loneliness. These behaviors and statuses can be approximated by the nearby Bluetooth device count (NBDC) detected by Bluetooth sensors in mobile phones.
OBJECTIVE
This study aimed to explore the value of the NBDC data in predicting depressive symptom severity as measured via the 8-item Patient Health Questionnaire (PHQ-8).
METHODS
The data used in this paper included 2886 biweekly PHQ-8 records collected from 316 participants recruited from three study sites in the Netherlands, Spain, and the United Kingdom as part of the EU Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) study. From the NBDC data 2 weeks prior to each PHQ-8 score, we extracted 49 Bluetooth features, including statistical features and nonlinear features for measuring the periodicity and regularity of individuals' life rhythms. Linear mixed-effect models were used to explore associations between Bluetooth features and the PHQ-8 score. We then applied hierarchical Bayesian linear regression models to predict the PHQ-8 score from the extracted Bluetooth features.
RESULTS
A number of significant associations were found between Bluetooth features and depressive symptom severity. Generally speaking, along with depressive symptom worsening, one or more of the following changes were found in the preceding 2 weeks of the NBDC data: (1) the amount decreased, (2) the variance decreased, (3) the periodicity (especially the circadian rhythm) decreased, and (4) the NBDC sequence became more irregular. Compared with commonly used machine learning models, the proposed hierarchical Bayesian linear regression model achieved the best prediction metrics (R
CONCLUSIONS
Our statistical results indicate that the NBDC data have the potential to reflect changes in individuals' behaviors and statuses concurrent with the changes in the depressive state. The prediction results demonstrate that the NBDC data have a significant value in predicting depressive symptom severity. These findings may have utility for the mental health monitoring practice in real-world settings.

Identifiants

pubmed: 34328441
pii: v9i7e29840
doi: 10.2196/29840
pmc: PMC8367113
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29840

Subventions

Organisme : NIMH NIH HHS
ID : P50 MH119029
Pays : United States
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17214
Pays : United Kingdom
Organisme : Alzheimer's Society
ID : 171
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH111610
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Chief Scientist Office
Pays : United Kingdom

Informations de copyright

©Yuezhou Zhang, Amos A Folarin, Shaoxiong Sun, Nicholas Cummins, Yatharth Ranjan, Zulqarnain Rashid, Pauline Conde, Callum Stewart, Petroula Laiou, Faith Matcham, Carolin Oetzmann, Femke Lamers, Sara Siddi, Sara Simblett, Aki Rintala, David C Mohr, Inez Myin-Germeys, Til Wykes, Josep Maria Haro, Brenda W J H Penninx, Vaibhav A Narayan, Peter Annas, Matthew Hotopf, Richard J B Dobson, RADAR-CNS Consortium. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 30.07.2021.

Références

Psychiatr Serv. 2000 Dec;51(12):1555-60
pubmed: 11097653
Can J Psychiatry. 2015 Jan;60(1):14-22
pubmed: 25886545
Psychol Aging. 2006 Mar;21(1):140-51
pubmed: 16594799
Aging Clin Exp Res. 2003 Jun;15(3):205-11
pubmed: 14582683
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:287-290
pubmed: 29059866
PLoS One. 2018 Mar 7;13(3):e0193971
pubmed: 29513754
JMIR Mhealth Uhealth. 2019 Aug 01;7(8):e11734
pubmed: 31373275
Clin Neurophysiol. 2010 Sep;121(9):1438-1446
pubmed: 20400371
J Sport Health Sci. 2016 Mar;5(1):44-51
pubmed: 30356502
JMIR Mhealth Uhealth. 2018 Aug 13;6(8):e165
pubmed: 30104184
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
JMIR Mhealth Uhealth. 2019 Jul 24;7(7):e13209
pubmed: 31342903
Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15274-8
pubmed: 19706491
PLoS One. 2019 Jul 26;14(7):e0218429
pubmed: 31348787
BMC Psychiatry. 2019 Feb 18;19(1):72
pubmed: 30777041
Biometrics. 1982 Dec;38(4):963-74
pubmed: 7168798
Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Feb;71(2 Pt 1):021906
pubmed: 15783351
J Med Internet Res. 2015 Jul 15;17(7):e175
pubmed: 26180009
Transl Psychiatry. 2020 Jan 23;10(1):28
pubmed: 32066704
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:5267-70
pubmed: 22255526
JMIR Mhealth Uhealth. 2020 Apr 1;8(4):e15028
pubmed: 32234702
Int J Ment Health Syst. 2007 Sep 04;1(1):4
pubmed: 18271976
Psychon Bull Rev. 2004 Oct;11(5):791-806
pubmed: 15732688
PeerJ. 2016 Sep 29;4:e2537
pubmed: 28344895
J Affect Disord. 2004 Jan;78(1):27-35
pubmed: 14672794
JMIR Mhealth Uhealth. 2021 Apr 12;9(4):e24604
pubmed: 33843591
J Med Internet Res. 2020 Sep 25;22(9):e19992
pubmed: 32877352
J Med Internet Res. 2017 Mar 03;19(3):e62
pubmed: 28258049

Auteurs

Yuezhou Zhang (Y)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Amos A Folarin (AA)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Institute of Health Informatics, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.
Health Data Research UK London, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Shaoxiong Sun (S)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Nicholas Cummins (N)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Yatharth Ranjan (Y)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Zulqarnain Rashid (Z)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Pauline Conde (P)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Callum Stewart (C)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Petroula Laiou (P)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Faith Matcham (F)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Carolin Oetzmann (C)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Femke Lamers (F)

Department of Psychiatry, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam University Medical Centre, Vrije Universiteit and GGZ InGeest, Amsterdam, Netherlands.

Sara Siddi (S)

Teaching Research and Innovation Unit, Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Sara Simblett (S)

Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Aki Rintala (A)

Center for Contextual Psychiatry, Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium.
Faculty of Social Services and Health Care, LAB University of Applied Sciences, Lahti, Finland.

David C Mohr (DC)

Center for Behavioral Intervention Technologies, Department of Preventive Medicine, Northwestern University, Evanston, IL, United States.

Inez Myin-Germeys (I)

Center for Contextual Psychiatry, Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium.

Til Wykes (T)

NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.
Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Josep Maria Haro (JM)

Teaching Research and Innovation Unit, Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Brenda W J H Penninx (BWJH)

Department of Psychiatry, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam University Medical Centre, Vrije Universiteit and GGZ InGeest, Amsterdam, Netherlands.

Vaibhav A Narayan (VA)

Janssen Research and Development LLC, Titusville, NJ, United States.

Peter Annas (P)

H Lundbeck A/S, Copenhagen, Denmark.

Matthew Hotopf (M)

NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Richard J B Dobson (RJB)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Institute of Health Informatics, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.
Health Data Research UK London, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH